Does Rosuvastatin/Ezetimibe Combination Therapy Offer Potential Benefits for Glucose Metabolism beyond Lipid-Lowering Efficacy in T2DM?
- Author:
Il Rae PARK
1
;
Jun Sung MOON
Author Information
- Publication Type:Editorial
- From:Diabetes & Metabolism Journal 2024;48(3):387-389
- CountryRepublic of Korea
- Language:English
